Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology Diabetes and Metabolism)
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Endocrinologist
MBBS, MCPS (Medicine), FCPS ( Medicine), FCPS (Endocrinology), SCE (Endocrinology & Diabetes, UK)
Endocrinologist
MBBS, MCPS (Medicine), FCPS ( Medicine), FCPS (Endocrinology), SCE (Endocrinology & Diabetes, UK)
Cardiologist
MBBS, FCPS (Medicine), FCPS (Cardiology)
Internal Medicine Specialist
MBBS, MCPS, Doctorate Of Medicine (M.D)
Diabetologist
MBBS, MCPS (Family Medicine), MRCGP
General Physician
M.B.B.S, M.Sc. (Physiology), D.Diab.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures